| Authors | Abhishek Maiti, Jorge Cortes, Alessandra Ferrajoli, Zeev Estrov, Gautam Borthakur, Guillermo Garcia-Manero, Elias Jabbour, Farhad Ravandi, Susan O'Brien, Hagop Kantarjian |
| Journal | Leukemia & lymphoma
(Leuk Lymphoma)
Vol. 58
Issue 9
Pg. 1-6
(09 2017)
ISSN: 1029-2403 [Electronic] United States |
| PMID | 28278723
(Publication Type: Clinical Trial, Phase II, Letter, Research Support, N.I.H., Extramural)
|
| Chemical References |
- Harringtonines
- Homoharringtonine
- Imatinib Mesylate
|
| Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Blast Crisis
- Female
- Harringtonines
(administration & dosage)
- Homoharringtonine
- Humans
- Imatinib Mesylate
(administration & dosage)
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
(drug therapy, mortality, pathology)
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Chronic-Phase
- Male
- Middle Aged
- Neoplasm Staging
- Retreatment
- Treatment Outcome
- Young Adult
|
